Form 8-K - Current report:
SEC Accession No. 0001654954-26-004910
Filing Date
2026-05-14
Accepted
2026-05-14 17:16:25
Documents
17
Period of Report
2026-05-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cvm_8k.htm   iXBRL 8-K 24277
2 AGREEMENT WITH AMAROX cvm_ex10sss.htm EX-10.SSS 20193
3 PRESS RELEASE cvm_ex99.htm EX-99 20232
9 cvm_ex99img4.jpg GRAPHIC 5087
10 cvm_ex99img6.jpg GRAPHIC 4328
  Complete submission text file 0001654954-26-004910.txt   202284

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cvm-20260511.xsd EX-101.SCH 5014
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvm-20260511_lab.xml EX-101.LAB 14667
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cvm-20260511_cal.xml EX-101.CAL 895
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvm-20260511_pre.xml EX-101.PRE 9272
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cvm-20260511_def.xml EX-101.DEF 2096
20 EXTRACTED XBRL INSTANCE DOCUMENT cvm_8k_htm.xml XML 3411
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-11889 | Film No.: 26980455
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)